简体中文 | 繁體中文 | English

Valeant, Allergan, and Pershing Square Have Agreed to Drop Lawsuit in Allergan v. Valeant Pharmaceuticals International

2015-04-10 15:01
  • 简体
  • 繁体
  • English

NEW YORK--()--Regulatory News:

Pershing Square Capital Management, L.P. has confirmed that on April 9, 2015 the parties to the lawsuit entitled Allergan, Inc., et al. v. Valeant Pharmaceuticals International, Inc., et al., No. 14-1214 DOC (ANx) (C.D. Cal.) have executed and filed with the court a Joint Stipulation of Voluntary Dismissal, dismissing the action.

About Pershing Square Capital Management, L.P.

Pershing Square Capital Management, L.P., based in New York City, is a SEC-registered investment advisor to private investment funds and to Pershing Square Holdings, Ltd.

About Pershing Square Holdings, Ltd.

Pershing Square Holdings, Ltd. is a concentrated, research-intensive, fundamental value investor in the public markets.

 

 

Contacts

Rubenstein Associates
Fran McGill, 212-843-9353
Fmcgill@rubenstein.com
or
StockWell Communications
Tim Burt, +44 (0)20 7240 2486
Tim.Burt@stockwellgroup.com